Overview

A Study to Estimate the Efficacy and Safety of Solifenacin in Female With Stress Urinary Incontinence and Urgency Urinary Incontinence

Status:
Completed

Trial end date:
2014-06-01

Target enrollment:

Participant gender:

Summary

This study is to investigate the effects of solifenacin on urgency urinary incontinence symptoms and incontinence quality-of-life (I-QoL) in female patients with clinically significant stress urinary incontinence accompanied by urgency urinary incontinence.

Phase:

Phase 4

Details

Lead Sponsor:

Jeong Gu Lee

Collaborator:

Astellas Pharma Korea, Inc.

Treatments:

Solifenacin Succinate